legal-news
1:23-cv-02939 JANSSEN PHARMACEUTICALS, INC. et al v. ALKEM LABORATORIES LTD. et al
23-cv-02939
|
|
Filed
Active
Sign in to follow this case
Advertisement
description
Case Summary
In the case 1:23-cv-02939 Janssen Pharmaceuticals, Inc. et al v. Alkem Laboratories Ltd. et al, Janssen Pharmaceuticals and its co-plaintiffs initiated litigation against Alkem Laboratories and other defendants. The dispute involves pharmaceutical products, likely concerning patent rights, regulatory compliance, or alleged infringement issues. The docket includes a letter filed in the case, indicating ongoing procedural communications between the parties or with the court. Specific details about the claims or defenses are not provided in the available information.
Key Issues
- • Pharmaceutical patent infringement
- • Regulatory compliance in drug manufacturing
- • Intellectual property rights enforcement
- • Procedural motions and court communications
Advertisement
Case Timeline
1 event
info
Other
April 14, 2026
1:23-cv-02939 JANSSEN PHARMACEUTICALS, INC. et al v. ALKEM LABORATORIES LTD. et al
[Letter] (<a href="https://ecf.njd.uscourts.gov/doc1/119023808056?caseid=513032&de_seq_num=920">306</a>)
Advertisement
newspaper
1 article